Transfer of Patients With Cardiogenic Shock Using Veno-Arterial Extracorporeal Membrane Oxygenation

被引:8
|
作者
Ali, Jason M. [1 ]
Vuylsteke, Alain [2 ]
Fowles, Jo-Anne [2 ]
Pettit, Stephen [3 ]
Salaunkey, Kiran [2 ]
Bhagra, Sai [3 ]
Lewis, Clive [3 ]
Parameshwar, Jayan [3 ]
Kydd, Anna [3 ]
Patvardhan, Chinmay [2 ]
Jones, Nicola [2 ]
Rubino, Antonio [2 ]
Abu-Omar, Yasir [1 ]
Sudarshan, Catherine [1 ]
Tsui, Steven [1 ]
Catarino, Pedro [1 ]
Jenkins, David P. [1 ]
Berman, Marius [1 ]
机构
[1] Royal Papworth Hosp, Dept Cardiothorac Surg, Cambridge Biomed Campus,Papworth Rd, Cambridge CB2 0AY, England
[2] Royal Papworth Hosp, Dept Intens Care, Cambridge Biomed Campus, Cambridge, England
[3] Royal Papworth Hosp, Dept Transplantat Cardiol, Cambridge Biomed Campus, Cambridge, England
关键词
cardiogenic shock; VA-ECMO; veno-arterial extracorporeal membrane oxygenation; transfer; POSITION PAPER; SUPPORT; TRANSPORT; TEAM; COMPLICATIONS; ORGANIZATION; PROGRAMS; FAILURE;
D O I
10.1053/j.jvca.2019.05.012
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: The authors describe the experience of patient transfer on veno-arterial extracorporeal membrane oxygenation (VA-ECMO) used as a salvage therapy for refractory cardiogenic shock, examining feasibility and long-term outcomes. Design: A retrospective case series. Setting: A tertiary referral cardiothoracic transplantation center. Participants and Interventions: Since 2012, the authors' multidisciplinary team has traveled to the referring center of 15 patients referred with refractory cardiogenic shock. Of these, 13 were instituted on VA ECMO support (8 peripheral and 5 central) and subsequently transferred to the authors' center. A further 11 patients were transferred to the authors' institution by the referring team, already having been placed on VAECMO (8 peripheral and 3 central). Measurements and Main Results: All patients were safely transferred. The distance travelled ranged from 16 to 341 miles. The median duration of support on VA-ECMO was 4 days, ranging from 1 to 24 days. The VA-ECMO support was weaned, or the patient underwent a definitive surgical management (including 4 undergoing cardiac transplantation and 3 pulmonary endarterectomy) in 15 (62.5%) patients. The median intensive care unit stay was 15 days (range 1-109). Overall 30-day survival for this patient cohort was 69.6% with 1-year survival of 59.8%. For patients who were weaned from VA-ECMO, the 30-day survival was 100% and 1-year survival 92.9%. Conclusions: The authors' experience demonstrates the feasibility and survival benefit of a salvage VA-ECMO retrieval service for carefully selected patients with refractory cardiogenic shock. The authors suggest that a system based on the model of nationally commissioned severe respiratory failure services could be organized to support the transfer of these patients. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:374 / 382
页数:9
相关论文
共 50 条
  • [1] Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock
    Jhand, Aravdeep
    Shabbir, Muhammad Asim
    Um, John
    Velagapudi, Poonam
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2023, (199): : 1 - 16
  • [2] Comparing Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) and Impella in Cardiogenic Shock Patients
    Thong Nguyen
    Cao, Xiangkun
    Malaver, Diego
    Zhao, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B278 - B278
  • [3] Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patients
    Pozzi, Matteo
    Banfi, Carlo
    Grinberg, Daniel
    Koffel, Catherine
    Bendjelid, Karim
    Robin, Jacques
    Giraud, Raphael
    Obadia, Jean Francois
    JOURNAL OF THORACIC DISEASE, 2016, 8 (07) : E495 - E502
  • [4] Sepsis in postcardiotomy cardiogenic shock patients supported with veno-arterial extracorporeal membrane oxygenation
    Tantway, Tarek M.
    Arafat, Amr A.
    Albabtain, Monirah A.
    Belghith, Makhlouf
    Osman, Ahmed A.
    Aboughanima, Mohamed A. A.
    Abdullatif, Muhammad T.
    Elshoura, Youssef A. A.
    AlBarak, Mohammed M.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2023, 46 (03): : 153 - 161
  • [5] Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock An Introduction for the Busy Clinician
    Eckman, Peter M.
    Katz, Jason N.
    El Banayosy, Aly
    Bohula, Erin A.
    Sun, Benjamin
    van Diepen, Sean
    CIRCULATION, 2019, 140 (24) : 2019 - 2037
  • [6] Interhospital stabilization of adult patients with refractory cardiogenic shock by veno-arterial extracorporeal membrane oxygenation
    Formica, Francesco
    Avalli, Leonello
    Redaelli, Gianluigi
    Paolini, Giovanni
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 (01) : 164 - 165
  • [7] Hemodynamic Management During Veno-Arterial Extracorporeal Membrane Oxygenation in Patients with Cardiogenic Shock: A Review
    Chengfen Yin
    Lei Xu
    Intensive Care Research, 2023, 3 (2): : 131 - 139
  • [8] Veno-arterial extracorporeal membrane oxygenation for severe cardiogenic shock secondary to phaeochromocytoma crisis
    Fung, R. K.
    Arumugam, D.
    Tjokrowidjaja, A.
    Forrest, P.
    Chua, E. L.
    Southwood, T.
    ANAESTHESIA AND INTENSIVE CARE, 2017, 45 (05) : 636 - 637
  • [9] Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock
    Kim, Hyungtae
    Lim, Sang-Hyun
    Hong, Joonhwa
    Hong, You-Sun
    Lee, Cheol Joo
    Jung, Joon-Ho
    Yu, Saehwan
    RESUSCITATION, 2012, 83 (08) : 971 - 975
  • [10] Complications of veno-arterial extracorporeal membrane oxygenation for refractory cardiogenic shock or cardiac arrest
    Lee, Soo Youn
    Jeon, Ki-Hyun
    Lee, Hyun Jong
    Kim, Ji-Bak
    Fang, Ho-Jun
    Kim, Je Sang
    Kim, Tae Hoon
    Park, Jin-Sik
    Choi, Rak Kyeong
    Choi, Young Jin
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2020, 43 (01): : 37 - 44